| Tretinoin | Approved Investigational Nutraceutical | S100A8 | 6279 |
upregulated | Tretinoin results in increased expression of S100A8 mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | S100A9 | 6280 |
upregulated | Tretinoin metabolite results in increased expression of S100A9 mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | S100A9 | 6280 |
downregulated | Tretinoin results in decreased expression of S100A9 mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | S100A9 | 6280 |
upregulated | Tretinoin results in increased expression of S100A9 mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | S100P | 6286 |
upregulated | Tretinoin results in increased expression of S100P mRNA | 4p16.1 | |
| Tretinoin | Approved Investigational Nutraceutical | S1PR3 | 1903 |
downregulated | Tretinoin results in decreased expression of S1PR3 mRNA | 9q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SAA1 | 6288 |
upregulated | Tretinoin results in increased expression of SAA1 mRNA | 11p15.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SAA2 | 6289 |
upregulated | Tretinoin results in increased expression of SAA2 mRNA | 11p15.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SACS | 26278 |
downregulated | Tretinoin results in decreased expression of SACS mRNA | 13q12.12 | |
| Tretinoin | Approved Investigational Nutraceutical | SALL2 | 6297 |
downregulated | Tretinoin results in decreased expression of SALL2 mRNA | 14q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SALL3 | 27164 |
downregulated | Tretinoin results in decreased expression of SALL3 mRNA | 18q23 | |
| Tretinoin | Approved Investigational Nutraceutical | SALL4 | 57167 |
downregulated | Tretinoin results in decreased expression of SALL4 mRNA | 20q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SAMD11 | 148398 |
downregulated | Tretinoin results in decreased expression of SAMD11 mRNA | 1p36.33 | |
| Tretinoin | Approved Investigational Nutraceutical | SAMD11 | 148398 |
upregulated | Tretinoin results in increased expression of SAMD11 mRNA | 1p36.33 | |
| Tretinoin | Approved Investigational Nutraceutical | SAMD12 | 401474 |
upregulated | Tretinoin results in increased expression of SAMD12 mRNA | 8q24.11-q24.12 | |
| Tretinoin | Approved Investigational Nutraceutical | SAMD4A | 23034 |
upregulated | Tretinoin results in increased expression of SAMD4A mRNA | 14q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SAMD5 | 389432 |
upregulated | Tretinoin results in increased expression of SAMD5 mRNA | 6q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SAMD9 | 54809 |
upregulated | Tretinoin results in increased expression of SAMD9 mRNA | 7q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SAMD9L | 219285 |
upregulated | Tretinoin results in increased expression of SAMD9L mRNA | 7q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SAMSN1 | 64092 |
upregulated | Tretinoin results in increased expression of SAMSN1 mRNA | 21q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SAP30 | 8819 |
downregulated | Tretinoin results in decreased expression of SAP30 mRNA | 4q34.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SAR1B | 51128 |
upregulated | Tretinoin results in increased expression of SAR1B mRNA | 5q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SART3 | 9733 |
downregulated | Tretinoin results in decreased expression of SART3 mRNA | 12q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SASH1 | 23328 |
upregulated | Tretinoin results in increased expression of SASH1 mRNA | 6q24.3-q25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SAT1 | 6303 |
upregulated | Tretinoin results in increased expression of SAT1 mRNA | Xp22.11 | |